Azithromycin for Child Survival in Niger: Delivery Trial
Status:
Recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
This cluster-randomized trial aims to compare the impact of different delivery approaches to
azithromycin distribution on coverage, costs, and feasibility outcomes. The investigators
hypothesize that door-to-door delivery will have higher coverage and costs and similar
feasibility and acceptability compared to fixed-point delivery.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Bill and Melinda Gates Foundation Programme National de Santé Oculaire, Ministère de la Santé Publique du Niger